J Bacteriol, July 1998, p. 3671-3680, Vol. 180, No. 14
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Department of Microbiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284-7758,1 and Max-Planck-Institut fuer Terrestrische Mikrobiologie, 35043 Marburg, Germany2
Received 3 February 1998/Accepted 11 May 1998
B, a transcription factor that controls the
Bacillus subtilis general stress response regulon, is
activated by either a drop in intracellular ATP or exposure to
environmental stress. RsbX, one of seven
B regulators
(Rsb proteins) whose genes are cotranscribed with
B, is
a negative regulator in the stress-dependent activation pathway. To
better define the interactions that take place among the Rsb proteins,
we analyzed sigB operon mutations which suppress
the high-level
B activity that normally accompanies the
loss of RsbX. Each of these mutations was in one of three genes
(rsbT, -U, and -V) which encode
positive regulators of
B, and they all defined amino
acid changes which either compromised the activities of the mutant Rsbs
or affected their ability to accumulate.
B activity
remained inducible by ethanol in several of the RsbX
suppressor strains. This finding supports the notion that RsbX is not
needed as the target for
B activation by at least some
stresses.
B activity in several RsbX
strains with suppressor mutations in rsbT or -U
was high during growth and underwent a continued, rather than a
transient, increase following stress. Thus, RsbX is likely responsible
for maintaining low
B activity during balanced growth
and for reestablishing
B activity at prestress
levels following induction. Although RsbX likely participates
in limiting the
B induction response, a second mechanism
for curtailing unrestricted
B activation was suggested
by the
B induction profile in two suppressor strains
with mutations in rsbV.
B activity in these
mutants was stress inducible but transient, even in the absence of
RsbX.
Present address: Institute of Structural Biology and Drug
Discovery, Virginia Commonwealth University, Richmond, VA 23239.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |